Basic Information
Basic information for AL022068.1-216-22aa
Peptide Name AL022068.1-216-22aa
Genome Position chr6:19720841-19720906[-]
Species Human
Peptide Sequence MLYLWGVASLFLKVFAIFFLCF
Peptide Length 22
Unique No (AL022068.1-226-22aa,AL022068.1-228-22aa,AL022068.1-213-22aa,AL022068.1-215-22aa)
Grand Average of Hydropathicity 2.1182
Relative Molecular Mass 3007.58
Experimental Evidences no
lncRNA ID/Name ENSG00000228412;AL022068.1
Transcript ID/Name ENST00000656719;AL022068.1-216
Transcript Length 1132
Coding Ability 0.2597
DNA Sequence Corresponding to Peptide ATGCTGTATTTATGGGGGGTGGCAAGTCTGTTTTTAAAAGTCTTTGCGATATTTTTTCTATGTTTT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :